Plus   Neg

Stock Alert: Black Diamond Therapeutics Up 13%

Shares of Black Diamond Therapeutics, Inc. (BDTX) are trading nearly 13% higher on Monday morning despite no stock-related news to help the shares.

U.S. stocks are gaining on Monday as investors are optimistic about resurgence of the global economy and major businesses despite spread of coronavirus failing to slow down.

BDTX is currently trading at $30.81, up $3.53 or 12.94%, on the Nasdaq.

Black Diamond Therapeutics is a Cambridge, Massachusetts-based precision oncology medicine company that pioneers in development of small molecule, tumor-agnostic therapies.

Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Agriculture's Food Safety and Inspection Service announced a Cooperative Interstate Shipment or CIS agreement with the State of Vermont. As per the deal, Vermont is allowed to operate a CIS program, with which certain state-inspected meat and poultry processors can ship their products across state lines, and expand their business opportunities. Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites.
Follow RTT